Bioorganic Chemistry Molecular Biology

Structure-guided optimization of benzo[d]oxazole-based NAMPT inhibitors against NAPRT-deficient cancers

Yeji Kim, Jooyoung Lee, Myung-Jeom Ryu, Jee Sun Yang, Chang-Mok Oh, Chulho Lee, Hyun Seok Kim, Gyoonhee Han
Elsevier · · DOI 10.2139/ssrn.7465323

Abstract

Nicotinamide phosphoribosyltransferase (NAMPT) has emerged as a therapeutic target for exploiting the metabolic vulnerability of NAPRT-deficient cancers. In this study, a structure-guided optimization strategy combining molecular docking and cellular antiproliferative assays was applied to nicotinamide-based NAMPT inhibitors. Sequential modification of the distal substituent, linker architecture, and benzo[d]oxazole scaffold enabled progressive refinement of structure-activity relationships and identification of structural features associated with improved activity. The optimized derivatives were subsequently evaluated across NSCLC cell lines with distinct NAPRT status to assess NAPRT-dependent selectivity, together with non-malignant bronchial epithelial cells. Representative compounds were further characterized by in silico ADMET analysis, plasma protein binding, and human liver microsomal stability assays. Overall, the study demonstrates that systematic optimization of benzo[d]oxazole-based NAMPT inhibitors can improve cellular activity and NAPRT-dependent selectivity, providing a basis for further development of selective agents against NAPRT-deficient cancers.

Read at publisher →